Skip to main content

Advertisement

SpringerLink
Log in

Switching and combining dopamine agonists

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary.

Switching from one dopamine agonist to another is common practice in the treatment of patients with Parkinson’s disease. This paper describes some ideas on the most practical way to perform switching. In addition, it describes the possibilities of combining various dopamine agonists and discusses pros and cons for doing so.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Department of Neurology, Technical University of Dresden, Dresden, Germany, , , , , , DE

    H. Reichmann, B. Herting, A. Mïller & U. Sommer

Authors
  1. H. Reichmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Herting
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Mïller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. U. Sommer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reichmann, H., Herting, B., Mïller, A. et al. Switching and combining dopamine agonists. J Neural Transm 110, 1393–1400 (2003). https://doi.org/10.1007/s00702-003-0081-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-003-0081-z

Search

Navigation